Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study - Wikidata - wikimedia - TriplyDB

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

http://www.wikidata.org/entity/Q35892768

about

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants Neuroplasticity and the next wave of antidepressant strategies Ketamine and other glutamate receptor modulators for depression in adults Rapid antidepressant effects: moving right along Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery Ketamine use in current clinical practice Kynurenine pathway metabolites and suicidality Ketamine, Transcranial Magnetic Stimulation, and Depression Specific Yoga and Mindfulness Based Cognitive Therapy in Management of Treatment Resistant Depression: Review and Some Data on Efficacy Pharmacological approaches to the challenge of treatment-resistant depression Legal highs: staying on top of the flood of novel psychoactive substances Ketamine, sleep, and depression: current status and new questions Antidepressant actions of ketamine: from molecular mechanisms to clinical practice Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy A brief history of the development of antidepressant drugs: from monoamines to glutamate The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder Experimental medication treatment approaches for depression.Do the dissociative side effects of ketamine mediate its antidepressant effects?Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice.Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.Baseline vitamin B12 and folate levels do not predict improvement in depression after a single infusion of ketamine.Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach The role of ketamine in treatment-resistant depression: a systematic review.Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.New targets for rapid antidepressant action.Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.Serial infusions of low-dose ketamine for major depression.Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.Riluzole likely lacks antidepressant efficacy in ketamine non-responders.Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases Clinical predictors of ketamine response in treatment-resistant major depression.Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.Does ketamine have anti-suicidal properties? Current status and future directions Ketamine as a promising prototype for a new generation of rapid-acting antidepressants.Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications.Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.

P2860

Q21129276-C26AA21B-8666-41A1-AD08-F5956676F89D Q21129480-625FE5EF-DEC8-435B-BD6D-0A5B238B7773 Q24186746-A16F566A-D31E-4DDE-8C66-AADED727B786 Q24614410-4BA36E7F-8AFC-426F-BAEF-483E7419F32F Q26749497-AB3C34AC-AE75-46F9-ACBE-1F55EEE5BCEF Q26750682-B0E7E693-7FBE-449A-BC7C-12C2EAC0BAD8 Q26773067-86FBEC68-9C3A-4DAF-9EE6-5EAD8673C866 Q26778251-50956A67-933C-4B4B-932E-EB9CFB819A9A Q26798241-4AB0DD7F-FBD8-4956-900F-BCF893000D2C Q26799231-DEE0CCE3-FF91-4B3D-893B-942AF6A7C3AF Q26828564-D21D1FD8-C0CA-40B4-978D-8F2B2E9CFA2F Q26995879-F57524EB-0861-47AC-A366-37E7314497FA Q27004490-80F6E2EA-B857-4F66-8C08-4F6FBB6E5C30 Q27024227-DAD73546-2D34-4B60-BF72-26D011D4FDA2 Q27028050-F187A328-F721-49FF-A00C-ACF6D6045486 Q30651146-D85721F6-8218-4154-8A4B-48C2BECB27A7 Q30711088-96319D49-B168-4E48-8ED0-A4D651534C0C Q33635577-EF85F6F2-CE4E-44F3-8DC6-642A056B799D Q33787133-7A7BC21E-FE41-4055-8D10-027C15396DA9 Q33864745-C4F650B6-315E-4F13-9DBE-42161E044E72 Q33874459-D9E8F96B-F78A-479A-835D-F2C40D6CACF1 Q34177760-86FF1B29-F7BF-42D6-B5C4-DD45A0F0E7D5 Q34241455-06B0FAA3-D3DC-49B8-AAC5-349FB6848DE9 Q34268501-E895984F-D49F-4051-B4F8-6FE24C0EB473 Q34449588-E9867BDD-F007-4D5A-806C-02613C69BBD9 Q34475595-883FE54B-12E8-43C9-8980-ACF4364A7D2C Q34507177-7CD8E81B-2900-4DAB-87DD-BE0653FA0743 Q34551188-B7AFA12E-D9F6-4725-B363-93482D5B9052 Q34640885-CF1C859B-A4B8-4519-A56C-AF26189F4548 Q34648663-F5836341-0DE9-436E-8766-202BF5131AFC Q34655680-ADF5528C-5E79-4940-96BF-5B549A0044F6 Q34989048-409C2FA1-31F0-4A18-BC56-B4859C4377E7 Q35001345-BB4F4064-5D4A-4433-BD0D-876D83181083 Q35020147-ABEBBB7E-686D-47F9-897A-FA5569639835 Q35026766-B7CCA372-1549-4ED6-9AA2-94ED84386F34 Q35150163-BDFB8AA6-471D-47D8-87E5-C6D06E9ECD79 Q35235620-EFA55CDC-A24A-434B-902F-75735011D0AD Q35547495-56C6D68A-1696-4010-A50F-E35EC43FBF93 Q35894579-32D5DFFF-3730-41FB-B4C1-F2B2B62D2563 Q35908061-36B59232-37B5-4EDF-BA48-6DA3A38F9E39

P2860

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

http://www.wikidata.org/entity/Q35892768

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Course of improvement in depre ...... lind, placebo-controlled study

@ast

Course of improvement in depre ...... lind, placebo-controlled study

@en

type

label

Course of improvement in depre ...... lind, placebo-controlled study

@ast

Course of improvement in depre ...... lind, placebo-controlled study

@en

prefLabel

Course of improvement in depre ...... lind, placebo-controlled study

@ast

Course of improvement in depre ...... lind, placebo-controlled study

@en

P1433

Q35892768-42028413-724A-451B-8080-BD55D954811C

P1476

Q35892768-7BFEDF00-82AC-4D12-856A-56FE942D1657

P2093

Q35892768-3C04E7D3-7DF2-41D6-8B59-8CA3462CF190

Q35892768-3D6D6841-AD4D-4729-A16C-39C9315C1172

Q35892768-958953C1-59AB-4481-8AA4-BA611416C995

Q35892768-96D90029-31BE-452D-BE1C-3C9E043B549D

Q35892768-C770D7D1-E171-4547-8A98-FB360817952C

Q35892768-D5B2DD23-5836-4454-9991-201FCC86766F

Q35892768-D8D39FEA-21FB-4CA6-8B1E-9DFE98553090

Q35892768-DE2E4D37-EB66-48E6-BF95-EF18F94054A9

Q35892768-EE8CF866-79C9-47BF-90CD-8C649EE513DE

P2860

Q35892768-034B740D-BD48-4628-8308-A21BC84726CA

Q35892768-094641F9-1875-4044-BDE7-91DF2E8215D9

Q35892768-184C7194-0C4B-43E8-93E2-1E1035EFD62D

Q35892768-1F4556C3-E37D-4A0D-9D83-016D9CD8F93B

Q35892768-22F4625B-2F0C-408F-9CD6-F3038BE360B5

Q35892768-2489EA96-5763-45A8-BF85-3DC6BFB793E2

Q35892768-26FB9D56-FD2D-45ED-A13B-037CD41FAB53

Q35892768-2C8D3F6C-F8C8-4D23-BFEB-90AB8514FA94

Q35892768-2D13B4BA-C66B-4A79-9108-AAE8CE571721

Q35892768-322CB43D-C6E8-4BFB-A17F-1CB34A6C07C2

P2888

Q35892768-41DE001B-6E94-4C85-B9EC-613895740A4D

P304

Q35892768-D1857591-EE01-4FBC-8192-576793808C43

P31

Q35892768-C9CEAFD5-BBD8-4D75-AF05-76C4E7637142

P356

Q35892768-7B57AF24-48DF-4D93-A16A-F6BDD04F2D2F

P407

Q35892768-5C62C52A-F311-4D49-BC38-BF39E717CB53

P433

Q35892768-C8AF4FDB-1EC8-48B3-8EE6-0EFD0A2F2FAC

P478

Q35892768-97E1DA86-39C5-4F7A-9B97-199E6A7B2E6E

P50

Q35892768-15A4CD13-91EE-4491-AD67-37226507600F

Q35892768-F467ABBB-54F7-4A9C-B5BC-325A96156CE6

P577

Q35892768-136E6255-B75A-485E-A9C6-75C3CEDD77BB

P5875

Q35892768-87AB1405-BEFD-4A4B-A319-60B16CDD95E0

P698

Q35892768-7C65250B-0116-40E7-BDA7-1A0D9D76302C

P921

Q35892768-277716B4-2927-4A61-970B-711C28692B9B

P932

Q35892768-6624B9F1-D570-4FB2-A46F-66549AB8B21B

P356

P1433

Neuropsychopharmacology

P1476

Course of improvement in depre ...... lind, placebo-controlled study

@en

P2093

Carlos A Zarate

http://www.w3.org/2001/XMLSchema#string

David A Luckenbaugh

http://www.w3.org/2001/XMLSchema#string

Husseini K Manji

http://www.w3.org/2001/XMLSchema#string

Irving Wainer

http://www.w3.org/2001/XMLSchema#string

Jose Franco-Chaves

http://www.w3.org/2001/XMLSchema#string

Lobna Ibrahim

http://www.w3.org/2001/XMLSchema#string

Nancy Brutsche

http://www.w3.org/2001/XMLSchema#string

Phillip Kronstein

http://www.w3.org/2001/XMLSchema#string

Ruin Moaddel

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

Assessment of suicidal intention: the Scale for Suicide Ideation

The assessment of anxiety states by rating

A new depression scale designed to be sensitive to change

Antidepressant effects of ketamine in depressed patients

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

A rating scale for mania: reliability, validity and sensitivity

Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo.

P2888

P304

1526-1533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2011.338

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

Nancy Diazgranados

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221799111

http://www.w3.org/2001/XMLSchema#string

P698

22298121

http://www.w3.org/2001/XMLSchema#string

P921

P932

3327857

http://www.w3.org/2001/XMLSchema#string